Sale!

MLL t4;11q21;q23 Qualitative Test Cost

Original price was: 1,200 د.إ.Current price is: 900 د.إ.

-25%

The MLL t(4;11)(q21;q23) Qualitative Test is a specialized diagnostic procedure designed to detect a specific chromosomal abnormality involving a translocation between chromosomes 4 and 11 at the q21 and q23 locations, respectively. This genetic anomaly is often associated with certain types of leukemia, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), particularly in pediatric patients. The test employs advanced molecular techniques to identify the presence of the MLL (Mixed Lineage Leukemia) gene rearrangement, which plays a crucial role in the development and prognosis of the disease.

Performed at DNA Labs UAE, a state-of-the-art facility known for its comprehensive genetic testing services, the MLL t(4;11)(q21;q23) Qualitative Test is conducted by a team of specialized professionals. The test cost is set at 900 AED, reflecting the sophisticated technology and expertise required to accurately detect and analyze this complex chromosomal translocation. By identifying the MLL gene rearrangement, healthcare providers can better understand the patient’s specific condition, enabling them to tailor treatment plans more effectively and potentially improve patient outcomes.

Description

MLL t4;11q21;q23 Qualitative Test – DNA Labs UAE

Test Name: MLL t4;11q21;q23 Qualitative Test

Components: EDTA Vacutainer (2ml)

Price: 900.0 AED

Sample Condition: Bone marrow / Peripheral blood (Transport immediately)

Report Delivery: 3-4 days

Method: Real Time PCR

Test type: Genetics

Doctor: General Physician

Test Department:

Pre Test Information: MLL t(4;11)(q21;q23) Qualitative can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

The MLL t(4;11)(q21;q23) translocation is a chromosomal abnormality that involves the rearrangement of genetic material between chromosomes 4 and 11. This translocation is commonly associated with acute lymphoblastic leukemia (ALL), particularly in children.

The term “qualitative” in this context refers to the type of analysis performed to detect the presence of the translocation. Qualitative analysis involves determining whether a specific genetic abnormality is present or absent, without providing information about the quantity or severity of the abnormality.

In the case of MLL t(4;11)(q21;q23), qualitative analysis would involve testing for the presence of the translocation in a patient’s cells or bone marrow sample. This can be done using various techniques, such as fluorescence in situ hybridization (FISH) or polymerase chain reaction (PCR), which can detect the specific genetic changes associated with this translocation.

Overall, qualitative analysis of MLL t(4;11)(q21;q23) is important for diagnosing and monitoring patients with acute lymphoblastic leukemia, as it helps to determine the presence or absence of this specific genetic abnormality, which can have implications for prognosis and treatment options.

Test Name	MLL t4;11q21;q23 Qualitative Test
Components	EDTA Vacutainer (2ml)
Price	900.0 AED
Sample Condition	Bone marrow \/ Peripheral blood (Transport immediately)
Report Delivery	3-4 days
Method	Real Time PCR
Test type	Genetics
Doctor	General Physician
Test Department:
Pre Test Information	MLL t(4;11)(q21;q23) Qualitative can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	The MLL t(4;11)(q21;q23) translocation is a chromosomal abnormality that involves the rearrangement of genetic material between chromosomes 4 and 11. This translocation is commonly associated with acute lymphoblastic leukemia (ALL), particularly in children. The term “qualitative” in this context refers to the type of analysis performed to detect the presence of the translocation. Qualitative analysis involves determining whether a specific genetic abnormality is present or absent, without providing information about the quantity or severity of the abnormality. In the case of MLL t(4;11)(q21;q23), qualitative analysis would involve testing for the presence of the translocation in a patient’s cells or bone marrow sample. This can be done using various techniques, such as fluorescence in situ hybridization (FISH) or polymerase chain reaction (PCR), which can detect the specific genetic changes associated with this translocation. Overall, qualitative analysis of MLL t(4;11)(q21;q23) is important for diagnosing and monitoring patients with acute lymphoblastic leukemia, as it helps to determine the presence or absence of this specific genetic abnormality, which can have implications for prognosis and treatment options.